表紙
市場調查報告書
商品編碼
1031163

器官移植免疫抑製劑市場:按藥物類別、按移植類型、按分銷渠道、按地區規模、份額、展望、機會分析(2018-2026)

Organ Transplant Immunosuppressant Drugs Market, by Drugs Class, by Therapeutic Organ Transplant Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

出版日期: | 出版商: Coherent Market Insights | 英文 210 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

成功的器官移植可能需要您服用免疫抑製藥物。這些藥物可防止免疫系統攻擊(拒絕)已移植的新器官。一般來說,它應該在你的餘生中服用,或者直到治療完成。這些藥物,當口服或靜脈給藥時,可以防止身體的免疫細胞進一步攻擊移植的器官。它還抑制對移植器官的過敏反應並抑制移植組織周圍的炎症。

在預測期內,新藥的批准和上市預計將推動全球器官移植免疫抑製藥物市場的增長。例如,2021 年 7 月,Kadmon Holdings, Inc. 獲得了美國食品藥品監督管理局的 REZUROCK(belumosudil)批准,用於治療患有慢性移植物抗宿主病的成人和兒童患者。

臨床試驗的負面結果預計將阻礙全球器官移植免疫抑製藥物市場的增長。例如,2021 年 9 月,諾華公司宣佈將停止旨在預防器官排斥的藥物的中期臨床試驗。這是因為腎移植患者的早期數據顯示,實驗性治療不如標準治療有效。

本報告調查了器官移植免疫抑製劑市場,提供了市場概況、藥物類別趨勢、器官移植治療類型、分銷渠道、地區以及進入市場的公司概況。

目錄

第 1 章調查目標/先決條件

    • 調查目的
    • 假設
    • 縮寫

第 2 章市場展望

    • 報告摘要
    • 市場定義和範圍
    • 執行摘要
    • 市場細分:按藥物類別
    • 市場細分:按移植類型
    • 市場細分:按分銷渠道
    • 相干機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

    • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 影響分析
    • 主要開發
    • 流行病學
    • 監管場景
    • 管道分析
    • PEST 分析
    • 兌換場景

第 4 章全球器官移植免疫抑製劑市場-冠狀病毒 (COVID-19) 大流行影響

    • Covid-19 的流行病學
    • 對每個國家的總體影響
    • 主要開發

第 5 章全球器官移植免疫抑製劑市場:按藥物類別,2017-2028(百萬美元)

    • 簡介
    • 2021 年和 2028 年市場份額分析 (%)
    • 2018-2028年同比增長分析
    • 細分趨勢
    • 鈣調神經磷酸□抑製劑
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 抗增殖劑
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • mTOR 抑製劑
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 類固醇
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 抗體
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢

第 6 章全球器官移植免疫抑製劑市場:按移植類型,2017-2028(百萬美元)

    • 簡介
    • 2021 年和 2028 年市場份額分析 (%)
    • 2018-2028年同比增長分析
    • 細分趨勢
    • 腎臟
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 肝臟
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 胰腺
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 其他
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢

第 7 章全球器官移植免疫抑製劑市場:按分銷渠道,2017-2028(百萬美元)

    • 簡介
    • 2021 年和 2028 年市場份額分析 (%)
    • 2018-2028年同比增長分析
    • 細分趨勢
    • 院內藥房
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 零售藥店
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢
    • 網上藥店
    • 簡介
    • 2017-2028 年市場規模和預測以及同比增長,(100 萬美元)
    • 細分趨勢

第 8 章全球器官移植免疫抑製劑市場:區域,2017-2028(100 萬美元)

    • 簡介
    • 2021 年和 2028 年市場份額分析 (%)
    • 2018-2028年同比增長分析
    • 區域趨勢
    • 北美
    • 簡介
    • 市場規模和預測,以及同比增長率:按藥物類別,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按移植類型,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長:按分銷渠道,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按國家劃分,2017-2028,(100 萬美元)
    • 美國
    • 加拿大
    • 拉丁美洲
    • 簡介
    • 市場規模和預測,以及同比增長率:按藥物類別,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按移植類型,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長:按分銷渠道,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按國家劃分,2017-2028,(100 萬美元)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
    • 歐洲
    • 簡介
    • 市場規模和預測,以及同比增長率:按藥物類別,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按移植類型,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長:按分銷渠道,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按國家劃分,2017-2028,(100 萬美元)
    • 英國
    • 德國
    • 意大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他
    • 亞太地區
    • 簡介
    • 市場規模和預測,以及同比增長率:按藥物類別,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按移植類型,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長:按分銷渠道,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按國家劃分,2017-2028,(100 萬美元)
    • 中國
    • 印度
    • 日本
    • 東盟
    • 澳大利亞
    • 韓國
    • 其他
    • 中東
    • 簡介
    • 市場規模和預測,以及同比增長率:按藥物類別,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按移植類型,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長:按分銷渠道,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按國家劃分,2017-2028,(100 萬美元)
    • 海灣合作委員會
    • 以色列
    • 其他
    • 非洲
    • 簡介
    • 市場規模和預測,以及同比增長率:按藥物類別,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按移植類型,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長:按分銷渠道,2017-2028,(100 萬美元)
    • 市場規模和預測,以及同比增長率:按國家劃分,2017-2028,(100 萬美元)
    • 北非
    • 中非
    • 南非

第 9 章競爭形勢

  • 企業簡介
    • Astellas Pharma
    • Genzyme Corporation
    • Accord Healthcare Ltd.
    • Watson Pharmaceuticals, Inc.
    • Novartis AG
    • Mylan Laboratories, Inc.
    • GlaxoSmithKline plc.
    • Belcher Pharmaceuticals LLC
    • Leo Pharma AS
    • Glenmark Pharmaceuticals Ltd.
    • TFF Pharmaceuticals, Inc.
    • TolerogenixX GmbH
    • Veloxis Pharmaceuticals Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Panacea Biotec Ltd.
    • Strides Pharma Global Pte Ltd.
    • F-Hoffman La Roche

第 10 章

目錄
Product Code: CMI2495

After a successful organ transplant, you may have to take immunosuppressant drugs. These drugs help your immune system from attacking (rejecting) the new organ from which it has been transplanted. In general, they should be taken for your lifetime, or until the treatments are complete. Orally, or injected into a vein, these drugs work by stopping your body's immune cells from further attacking your transplanted organ. They also control your allergic reactions to the transplanted organ and reduce inflammation around the transplanted tissues.

Market Dynamics:

Approval and launch of new drugs is expected to propel growth of the global organ transplant immunosuppressant drugs market over the forecast period. For instance, in July 2021, Kadmon Holdings, Inc. received the U.S. Food and Drug Administration approval for REZUROCK (belumosudil) for the treatment of adult and pediatric patients with chronic graft-versus-host disease.

Negative outcomes in clinical trials is expected to hinder growth of the global organ transplant immunosuppressant drugs market. For instance, in September 2021, Novartis AG announced to halt a mid-stage clinical trial of drug intended to prevent organ rejection after an early look at data in kidney transplant patients showed the experimental treatment was less effective compared to the standard of care therapy.

The market is witnessing several M&A activities. For instance, in September 2021, Sanofi announced to acquire Kadmon Holdings, a U.S.-based biopharmaceutical company.

Key features of the study:

  • This report provides in-depth analysis of the global organ transplant immunosuppressant drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global organ transplant immunosuppressant drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Astellas Pharma, Genzyme Corporation, Accord Healthcare Ltd., Watson Pharmaceuticals, Inc., Novartis AG, Mylan Laboratories, Inc., GlaxoSmithKline plc., Belcher Pharmaceuticals LLC, Leo Pharma As, Glenmark Pharmaceuticals Ltd., TFF Pharmaceuticals, Inc., TolerogenixX GmbH, Veloxis Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Panacea Biotec Ltd., Strides Pharma Global Pte Ltd., and Hoffman La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global organ transplant immunosuppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global organ transplant immunosuppressant drugs market

Detailed Segmentation:

  • Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
    • Calcineurin Inhibitors
    • Antiproliferative Agents
    • mTOR Inhibitor
    • Steroids
    • Antibodies
  • Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
    • Kidney
    • Liver
    • Heart
    • Lung
    • Pancreas
    • Others
  • Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Organ Transplant Immunosuppressant Drugs Market, By Region:
    • North America
      • North America Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
      • Calcineurin Inhibitors
      • Antiproliferative Agents
      • mTOR Inhibitor
      • Steroids
      • Antibodies
      • North America Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
      • Kidney
      • Liver
      • Heart
      • Lung
      • Pancreas
      • Others
      • North America Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • North America Organ Transplant Immunosuppressant Drugs Market , By Country:
      • U.S.
      • Canada
    • Latin America
      • Latin America Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
      • Calcineurin Inhibitors
      • Antiproliferative Agents
      • mTOR Inhibitor
      • Steroids
      • Antibodies
      • Latin America Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
      • Kidney
      • Liver
      • Heart
      • Lung
      • Pancreas
      • Others
      • Latin America Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Latin America Organ Transplant Immunosuppressant Drugs Market , By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Europe Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
      • Calcineurin Inhibitors
      • Antiproliferative Agents
      • mTOR Inhibitor
      • Steroids
      • Antibodies
      • Europe Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
      • Kidney
      • Liver
      • Heart
      • Lung
      • Pancreas
      • Others
      • Europe Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Europe Organ Transplant Immunosuppressant Drugs Market , By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • Asia Pacific Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
      • Calcineurin Inhibitors
      • Antiproliferative Agents
      • mTOR Inhibitor
      • Steroids
      • Antibodies
      • Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
      • Kidney
      • Liver
      • Heart
      • Lung
      • Pancreas
      • Others
      • Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • Middle East Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
      • Calcineurin Inhibitors
      • Antiproliferative Agents
      • mTOR Inhibitor
      • Steroids
      • Antibodies
      • Middle East Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
      • Kidney
      • Liver
      • Heart
      • Lung
      • Pancreas
      • Others
      • Middle East Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Middle East Organ Transplant Immunosuppressant Drugs Market, By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • Africa Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
      • Calcineurin Inhibitors
      • Antiproliferative Agents
      • mTOR Inhibitor
      • Steroids
      • Antibodies
      • Middle East Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
      • Kidney
      • Liver
      • Heart
      • Lung
      • Pancreas
      • Others
      • Middle East Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Middle East Organ Transplant Immunosuppressant Drugs Market, By Country:
      • North Africa
      • Central Africa
      • South Africa
  • Company Profiles
    • Astellas Pharma*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategy
    • Genzyme Corporation
    • Accord Healthcare Ltd.
    • Watson Pharmaceuticals, Inc.
    • Novartis AG
    • Mylan Laboratories, Inc.
    • GlaxoSmithKline plc.
    • Belcher Pharmaceuticals LLC
    • Leo Pharma AS
    • Glenmark Pharmaceuticals Ltd.
    • TFF Pharmaceuticals, Inc.
    • TolerogenixX GmbH
    • Veloxis Pharmaceuticals Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Panacea Biotec Ltd.
    • Strides Pharma Global Pte Ltd.
    • F-Hoffman La Roche

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Transplant Type
    • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Epidemiology
    • Regulatory Scenario
    • Pipeline Analysis
    • PEST Analysis
    • Reimbursement Scenario

4. Global Organ Transplant Immunosuppressant Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

    • Covid-19 Epidemiology
    • Overall Impact On Countries
    • Key Developments

5. Global Organ Transplant Immunosuppressant Drugs Market, By Drug Type, 2017 - 2028 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018-2028
    • Segment Trends
    • Calcineurin Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Antiproliferative Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • mTOR Inhibitor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Steroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends

6. Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2017 - 2028 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018-2028
    • Segment Trends
    • Kidney
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Liver
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Heart
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Lung
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Pancreas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends

7. Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel, 2017 - 2028 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018-2028
    • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends

8. Global Organ Transplant Immunosuppressant Drugs Market, By Region, 2017 - 2028 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018-2028
    • Regional Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transplant Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

    • Company Profiles
    • Astellas Pharma
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Genzyme Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Accord Healthcare Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Watson Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Mylan Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Belcher Pharmaceuticals LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Leo Pharma AS
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Glenmark Pharmaceuticals Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • TFF Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • TolerogenixX GmbH
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Veloxis Pharmaceuticals Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Dr. Reddy's Laboratories Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Panacea Biotec Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Strides Pharma Global Pte Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • F-Hoffman La Roche
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

    • References
    • Research Methodology
    • About us and Sales Contact